Journal
BIOMETALS
Volume 25, Issue 6, Pages 1247-1259Publisher
SPRINGER
DOI: 10.1007/s10534-012-9586-y
Keywords
Lactoferrin; Transferrin; Ceruloplasmin; Erythropoietin; Desferoxamin; Iron chelator; Hypoxia-inducible factor-1 alpha
Categories
Funding
- RFBR [09-04-00742, 09-04-01059]
Ask authors/readers for more resources
Apo-form of human lactoferrin (LF) is a potent iron chelator, this feature being similar to the iron-binding properties of a synthetic chelator desferoxamine (DFO). The latter stabilizes the principal adaptive transcriptional hypoxia-inducible factor-1 alpha (HIF-1 alpha). Since DFO is known as a pharmacological mimetic of hypoxia it was decided to test whether apo-LF is able to perform as such. Mice either injected intraperitoneally or given per os apo-LF displayed HIF-1 alpha in liver, lungs, heart, brain, spleen and kidneys, as judged by results of Western blotting. Similar administration of iron-saturated LF (75 mg/kg) did not bring forth such effect. Synthesis of erythropoietin and ceruloplasmin became increased in the first case, which is explained by the respective genes being targets for HIF-1 alpha. Apo-LF, but not Fe-LF, injected intraperitoneally to hypoxia low-resistant mice 24 h before animals were subjected to normobaric hypoxia with hypercapnia caused a significant increase of life-time by 40 %. The results obtained show that, like DFO, apo-LF performs as a normoxic mimetic of hypoxia, capable of stabilizing HIF-1 alpha. Protective features of LF and DFO and their pharmacological properties involving HIF-1 alpha are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available